Clinical Trial Update: Open-Label Study of OTO-201 for Treatment of AOMT [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial evaluating OTO-201 for Acute Otitis Media (AOM) and AOMT has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media

Drugs mentioned

• OTO-201

Snippet

Sponsor: Otonomy, Inc. | Conditions: Acute Otitis Media, AOMT | Phase 2 | Status: COMPLETED | Results posted: 2020-09-23